The HCCH IPO carries a contradiction worth examining closely. On Monday, Coca-Cola confirmed it is exploring a public listing of Hindustan Coca-Cola Holdings on the BSE and NSE in 2027 — yet the bottling unit’s FY25 revenue fell roughly 9% to ₹12,751 crore, even as the targeted valuation reportedly sits near $10 billion. That figure is almost 2.7 times the ₹31,250 crore enterprise value implied when Jubilant Bhartia Group acquired its 40% stake barely eighteen months earlier.
That gap demands unpacking. The December 2024 transaction priced HCCH at around ₹31,250 crore, with Jubilant paying approximately ₹12,500 crore for its stake through a mix of family equity and debt arranged partly via Goldman Sachs. The deal closed in July 2025, and the Bhartia family — which also operates Domino’s Pizza in India through Jubilant FoodWorks — is now a significant co-owner alongside Coca-Cola’s remaining 60%. A $10 billion listing target translates to roughly ₹85,000 crore at current exchange rates, implying a revenue multiple of nearly 6.5 times FY25 sales. For a bottler running 14 plants across ten states and reaching 1.7 million-plus retail outlets, that premium would place HCCB alongside India’s most richly valued consumer franchises.
India’s MNC listing playbook offers some justification for the leap. Indian capital markets have consistently rewarded foreign-parent subsidiaries with valuations far above what the same businesses fetch globally. Hyundai Motor India’s $3.3 billion IPO in late 2024 and LG Electronics India’s ₹15,000 crore offering in October 2025 both showed that domestic investors will pay steep multiples for well-known consumer brands with deep distribution. Coca-Cola has retained Rothschild as adviser and reportedly appointed Kotak, HDFC Group, and Citibank as bankers — a lineup that signals confidence in capturing this premium. The HCCH IPO also completes the company’s global asset-light refranchising strategy: having sold 40% to Jubilant and now planning to divest further through public markets, Coca-Cola can redirect capital toward brand-building while retaining a meaningful shareholder seat.
Investors should weigh what sits on the other side of the ledger. The 9% FY25 revenue decline — attributed partly to the sale of refranchised plants — makes HCCB’s organic growth trajectory harder to read from headline numbers alone. In FY24, revenue stood at ₹14,021 crore and net profit surged 247% to ₹2,808 crore, but the subsequent topline drop clouds whether that profitability spike is sustainable. Meanwhile, Reliance’s Campa Cola brand has been aggressively pricing 200 ml bottles at just ₹10, pressuring the mass end of India’s carbonated-drinks market where volume growth matters most. The valuation jump from ₹31,250 crore to ₹85,000 crore in under three years implies either that Jubilant secured a significant entry discount or the public market is being asked to price in years of growth that have not yet materialised — a distinction the SEBI offer documents will eventually have to clarify.
The listing remains subject to market conditions and regulatory approvals. For shareholders tracking this space, two things are worth monitoring as filings emerge: HCCB’s FY26 revenue figures, which will reveal whether the topline decline was a one-off accounting adjustment or a genuine slowdown, and the offer structure itself — whether Coca-Cola sells down aggressively or retains a controlling position will signal how much conviction the parent truly has in India’s consumption story beyond the IPO event. Related reading on recent MNC listings in India may help put this in broader context.
Found this analysis useful? Share it with a fellow investor who’s tracking the HCCH IPO.
